{
    "organizations": [],
    "uuid": "683074625a7bf23a8a319a8057a4f715aa5b669e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-odonate-therapeutics-q4-loss-per-s/brief-odonate-therapeutics-q4-loss-per-share-0-81-idUSASB0C5O5",
    "ord_in_thread": 0,
    "title": "BRIEF-Odonate Therapeutics Q4 Loss Per Share $0.81",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 14 (Reuters) - Odonate Therapeutics Inc:\n* ODONATE THERAPEUTICS ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND TWELVE MONTHS ENDED DECEMBER 31, 2017\n* Q4 LOSS PER SHARE $0.81 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-14T21:31:00.000+02:00",
    "crawled": "2018-02-15T20:49:48.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "odonate",
        "therapeutic",
        "inc",
        "odonate",
        "therapeutic",
        "announces",
        "financial",
        "result",
        "three",
        "twelve",
        "month",
        "ended",
        "december",
        "q4",
        "loss",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}